President and Chief Executive Officer MD/Ph.D.
His recent research topic was in Automated assessment of the substantia nigra on susceptibility map-weighted imaging using deep convolutional neural networks for diagnosis of Idiopathic Parkinson’s disease, which has been published in Parkinsonism and Related Disorders (VOLUME 85, P84-90, APRIL 01, 2021).
Director of Science & Marketing & BD, Ph.D.
He obtained a Ph.D. in Bio-Medical Science from Korea University, and has been involved in protocol research and development and marketing in the MRI field for over 15 years. He has also performed a number of research tasks and business development related to diagnostic imaging analysis program. Based on this experience, it has given scientific value for the useful Heuron’s product, and as a Clinical Scientist for collaboration with customers in clinical practice.
Head of Strategic Planning Division
He completed his Bachelor’s and Master’s degree in technical business at Sogang University, and doctoral course in international management at Hanyang University.He was a head of investment strategy team at KITIA(Korea Core Industrial Technology Investment Association) under MOTIE(Ministry of Trade, Industry and Energy) and performed various tasks such as overseas M&A deal sourcing and brokerage, negotiation support, new technology FDI support, improvement of financial investment system, VC investment link, and investment review.
Director of Development
Director of IP, Patent Attorney
He worked as a sales and marketing representative for JW medical and was a head of marketing at Samsung Madison, a global leading medical device company.
He is also the first generation to introduce PACS in Korea as the vice president of Infinitt Healthcare.
He graduated from Korea University’s Graduate School of Computer information and Communication.